TS
Tajendar Singh Kalra
About Tajendar Singh Kalra
Tajendar Singh Kalra has 16 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Valka Care And Services Private Limited and Dayachand Care And Cure Hospital And Diagnostic Centre Private Limited. Formerly with 1 company, such as Aqua Solutions Consultants Private Limited. Engaged in General Business.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Valka Care And Services Private Limited
U52500MP2012PTC029376
|
Managing Director | 16 Oct 2012 | 2012 | Active |
Dayachand Care And Cure Hospital And Diagnostic Centre Private Limited
U85300MP2022PTC063657
|
Director | 06 Dec 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Aqua Solutions Consultants Private Limited
U90002MP2009PTC022484
|
Director | 21 Dec 2009 | 2009 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tajendar Singh Kalra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tajendar Singh Kalra
Tajendar Singh Kalra has 16 years in corporate governance. Holds Managing Director and Director roles. Currently with 2 companies, including Valka Care And Services Private Limited and Dayachand Care And Cure Hospital And Diagnostic Centre Private Limited. Formerly with 1 company, such as Aqua Solutions Consultants Private Limited. Engaged in General Business.
Tajendar Singh Kalra is associated with 2 companies as Managing Director and Director.
Tajendar Singh Kalra has expertise in General Business.
Tajendar Singh Kalra has 16 years in corporate governance.